Strides Pharma Science has been recognized in the S&P Global Sustainability Yearbook 2025, placing it among the top 10% of companies worldwide for its strong Environmental, Social, and Governance (ESG) performance. This achievement underscores the company’s dedication to sustainability and responsible business practices.

The S&P Global Sustainability Yearbook evaluates companies across industries based on ESG performance. For the 2025 edition, 7,690 companies from over 60 industries were assessed, with 780 making it into the Yearbook. In the pharmaceutical and biotechnology sector, 35 companies were featured globally, 16 of which ranked in the top 10%. Among the 51 Indian companies recognized, five pharmaceutical firms secured a position in the top 5% or 10%.

Strides Pharma demonstrated outstanding ESG performance. It ranked 87th percentile in Environmental Stewardship, with its waste management efforts placing it in the 99th percentile. The company also achieved a 94th percentile ranking in Energy Management and Environmental Policy. In Social Responsibility, it secured a 97th percentile rank, with 100th percentile recognition in Customer Relations and high rankings in Human Capital Management (96%) and Societal Healthcare Contribution (95%). Additionally, it ranked 94th percentile in Business Ethics, excelling in Policy Influence and Crisis Management.

This recognition highlights Strides Pharma’s ongoing commitment to sustainability and its focus on integrating ESG principles into its long-term growth strategy.